Plus Products Inc. (CNSX: PLUS) CEO Jake Heimark on Partnering with John Legend and Casper

Plus Products Inc.CEO Jake Heimark on Partnering with John Legend and Casper

Plus Products Inc (CNSX: PLUS) (OTCMKTS: PLPRF) CEO Jake Heimark joins Midas Letter to discuss the company’s partnership announcements with John Legend and Casper Sleep. The singer, songwriter, producer, actor and philanthropist’s role in the partnership is to promote the company’s new hemp CBD product offering. Casper Sleep will introduce its melatonin and CBD-infused SLEEP … Read more

Liberty Health Sciences CEO: Florida is a Bigger Cannabis Opportunity Than Canada

Liberty Health Sciences CEO-Florida is a Bigger Cannabis Opportunity Than Canada

Liberty Health Sciences Inc. (CSE:LHS) is a vertically-integrated operator of U.S. focused cannabis businesses. The Company is looking to occupy the leadership position in Florida’s medical cannabis market and has plans to move into Massachusetts next. Speaking to SmallCapPower at the recent Benzinga Cannabis Capital Conference, CEO George Scorsis says, “with $30 million in deployable … Read more

Liberty Health Sciences CEO George Scorsis, Dmitry Zaytsev & James in Miami – Midas Letter 119

Liberty Health Sciences CEO George Scorsis, Dmitry Zaytsev & James in Miami - Midas Letter 119

Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. Ed Milewski and Brandon Colwell provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business.

Liberty Health Sciences Inc (CNSX:LHS) Response to Short-Seller Report

Liberty Health Sciences Inc Response to Short-Seller Report

Liberty Health Sciences Inc (CNSX:LHS) (OTCMKTS:LHSIF) (FRA:S6UQ) CEO George Scorsis responds to the second Hindenburg Research report. Scorsis highlights the self-interest of short sellers as well as the many inaccurate statements in the report in defense of Liberty Health’s practices. Scorsis clears up a misunderstanding about an early stage private placement, in which shares were … Read more

Liberty Health Sciences gets approval to implement FlorPass

Liberty Health Sciences gets approval to implement FlorPass

Liberty Health Sciences Inc (CNSX:LHS) CEO George Scorsis tells Proactive Investors the Canadian cannabis company has just received an important approval from the Florida Department of Health to implement the state’s first online patient management system, called FlorPass, which connects eligible patients with physicians and medical cannabis retailers. Scorsis says in addition to this approval, … Read more

Liberty Health Sciences Inc’s (CNSX:LHS) Success in Florida Market

Liberty Health Sciences Inc’s (CNSX:LHS) Success in Florida Market

Liberty Health Sciences Inc (CNSX:LHS) (OTCMKTS:LHSIF) (FRA:S6UQ) CEO George Scorsis provides an update on Liberty Health’s recent activities including its recent stock surge, its deal with PAX, and its foray into the Florida market. PAX produces temperature controlled portable cannabis oil vaporizers that Liberty Health will distribute in Florida through its dispensaries. Scorsis discusses the … Read more